(PharmaNewsWire.Com, January 15, 2018 ) According to Publisher, the Global Orthopaedic Imaging market is expected to grow from $7.85 billion in 2016 to reach $11.20 billion by 2023 with a CAGR of 5.2%. Growing incidences of several orthopedic disorders, advent of 3D imaging technology and rising preference to portable point-of-care devices are the some of the key factors driving the market growth. However, lack of skilled radiologists and increasing cost of clinical trials are restricting the market. Continuous efforts are being made by research institutes and medical organizations towards the development of advanced imaging devices which also fuels the market growth.
By product, X-ray system is the most commonly used widely available diagnostic imaging technique. X-rays can be used to diagnose fractures and dislocations, and also to assess fracture healing. An X-ray sends beams of radiation that pass through the skin and underlying tissues (muscle, ligaments and tendons) , when the beams meet the bone, an image is created. These images can be detected with analog (x-ray film) or digital systems directly on the computer. Objects that are more dense, such as bone, absorb more radiation while objects that are less dense, such as soft tissue, absorb less radiation.
Geographically, North America is anticipated to witness the largest market share during the forecast period. Advanced healthcare infrastructure, technological advancements and existence of huge market players are the factors contributing to the growth of the market in this region. In addition, Asia Pacific region is expected to grow at a faster rate due to growing population and rising occurrence of chronic diseases.
Some of the key players in the Orthopaedic Imaging market are Siemens Healthcare Private Limited, Toshiba Medical Systems Corporation (TMSC) , General Electric Company, Hitachi Medical Corporation, Philips Healthcare, Genesis Medical Imaging inc., Fujifilm Holdings Corporation, Sectra AB, Carestream Health, Shimadzu Corporation, Hologic Inc, ARTANN Laboratories, Inc, Emovi inc, Esaote SpA, Imaging Equipment Ltd and Planmed Oy.
Products Covered: -Fluoroscopy -X-Ray -Positron Emission Tomography (PET) -EOS Imaging Systems -Conventional radiography -Arthrography -Ultrasound -Scintigraphy (Radionuclide Bone Scan) -Magnetic Resonance Imaging (MRI) -Dual Energy X-Ray Absorptiometry (DEXA or DXA) -CT-Scanner
End Users Covered: -Ambulatory Surgery Center (ASCs) -Radiology Centers -Hospitals
Regions Covered: -North America -US -Canada -Mexico -Europe -Germany -UK -France -Italy -Spain -Rest of Europe -Asia Pacific -Japan -China -India -Australia -New Zealand -South Korea -Rest of Asia Pacific -South America -Argentina -Brazil -Chile -Rest of South America -Middle East & Africa -Saudi Arabia -UAE -Qatar -South Africa -Rest of Middle East & Africa
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
